Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Uncategorized

Rosenblatt Maintains Buy on IDEX, Raises Price Target to $255

Rosenblatt analyst Scott Graham maintains IDEX (NYSE:IEX) with a Buy and raises the price target from $225 to $255.

byBenzinga Newsdesk

May 3, 2021

1 minute read

Rosenblatt analyst Scott Graham maintains IDEX (NYSE:IEX) with a Buy and raises the price target from $225 to $255.

Insurance Stocks Moving In Tuesday’s Intraday Session

By Benzinga Insights

Today, 5:39 AM

According to Benzinga Pro following are the gainers and losers in Insurance industry for today's Intraday session.

ALL

Movers

11 Consumer Discretionary Stocks Moving In Friday’s Intraday Session

By Benzinga Insights

Today, 5:39 AM

Gainers

BARK

Palantir CEO’s Message To Tech Workers Critical Of Its Military Deals: ‘Bless You, Don’t Work Here’

By Shivdeep Dhaliwal

Today, 5:39 AM

Palantir Technologies Inc (NYSE: PLTR) CEO Alex Karp addressed tech workers who can’t stomach the company’s deals with military and government agencies at the World Economic Forum in Davos.

PLTR

Earnings

Avidity Biosciences: Q4 Earnings Insights

By Benzinga Insights

Today, 5:39 AM

Avidity Biosciences (NASDAQ:RNA) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

RNA

Rosenblatt Maintains Buy on IDEX, Raises Price Target to $255

Related Posts

Insurance Stocks Moving In Tuesday’s Intraday Session

11 Consumer Discretionary Stocks Moving In Friday’s Intraday Session

Palantir CEO’s Message To Tech Workers Critical Of Its Military Deals: ‘Bless You, Don’t Work Here’

Avidity Biosciences: Q4 Earnings Insights